Skip to content

Postoperative Noninvasive Ventilation After Upper Abdominal Surgery in Chronic Obstructive Lung Disease

Postoperative Noninvasive Ventilation After Upper Abdominal Surgery in Chronic Obstructive Lung Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04877353
Enrollment
100
Registered
2021-05-07
Start date
2019-01-01
Completion date
2020-11-15
Last updated
2021-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure Post Surgical (Diagnosis)

Keywords

noninvasive ventilation, COPD, acute respiratory failure

Brief summary

In Qena university hospital a prospective, randomized study was carried out on 100 COPD patients, all were divided into; conventional therapy without NIV (C group) 50 patients or with prophylactic NIV(N group) 50 patients.NIV applied for approximately 30 to 45 min at 2- to 4-h intervals for 48 h following surgery . Primary endpoint was the acute respiratory events (ARE) .Secondary endpoints were acute respiratory failure (ARF), intubation rate, mortality rate, infectious and non-infectious complications, and ICU stay.

Interventions

DEVICENIV

NIV applied for approximately 30 to 45 min at 2- to 4-h intervals for 48 h following surgery

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Postoperative NIV

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Inclusion criteria: * Age˃18 years, scheduled for upper abdominal surgery under general anesthesia. * Moderate to very severe COPD (GOLD II to IV). * ASA functional status II or greater. 2.

Exclusion criteria

* Contraindications to the application of NIV. * Sleep apnea syndrome. * Facial deformation. * Inability to follow the study.

Design outcomes

Primary

MeasureTime frameDescription
acute respiratory events28dayspatients %

Secondary

MeasureTime frameDescription
acute respiratory failure28 dayspatients %
intubation rate28 dayspatients %
ICU mortality28 dayspatients %
ICU length of stay28 daysdays
infectious and non infectious complications28 dayspatients %

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026